Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

935.58 -18.94 (-1.98%)

Official Closing Price Updated: 7:00 PM EDT, Apr 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Hasbro's Q1 2026 Earnings: What to Expect

April 01, 2026

Hasbro is expected to announce its first-quarter results soon, and analysts are projecting a single-digit decline in its EPS.

Via Barchart.com

Topics ETFs Workforce

What to Expect From Nasdaq's Q1 2026 Earnings Report

April 01, 2026

Nasdaq will release its first-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.

Via Barchart.com

Topics ETFs Workforce

Willis Towers Watson's Q1 2026 Earnings: What to Expect

April 01, 2026

Willis Towers Watson will release its first-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.

Via Barchart.com

Topics Artificial Intelligence ETFs Workforce

Eli Lilly & Co (NYSE:LLY): A Prime Dividend Growth Candidate Backed by Strong Profitability ↗

March 30, 2026

Via Chartmill

Wall Street Ends a Rough Quarter With Its Best Day, Iran Hope Ignites the Rally ↗

April 01, 2026

Via Chartmill

Why Centessa Stock Soared Today ↗

March 31, 2026

A pharma giant wants to buy the innovative drug developer.

Via The Motley Fool

Is This Weight Loss Drug Stock a Buy After a New Approval? ↗

March 31, 2026

This little-known biotech company has a different strategy than the established weight-loss drug market leaders. But is it likely to be successful?

Via The Motley Fool

Eli Lilly Expands Into Sleep Medicine With Centessa Buyout ↗

March 31, 2026

Eli Lilly to acquire Centessa Pharmaceuticals for $6.3B. CNTA stock surges 45% as Lilly expands its neuroscience and sleep medicine pipeline.

Via Benzinga

Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit?

March 31, 2026

Eli Lilly has expanded its partnership with Insilico Medicine to bring AI developed medicine into global market.

Via Barchart.com

Topics Artificial Intelligence

The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals

March 31, 2026

Today, March 31, 2026, the biotechnology landscape has been fundamentally reshaped. Eli Lilly and Company (NYSE: LLY) has officially announced a definitive agreement to acquire Centessa Pharmaceuticals...

Via Finterra

Topics Economy Initial Public Offering Intellectual Property

The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience

March 31, 2026

Date: March 31, 2026 Introduction In the spring of 2026, the global pharmaceutical landscape is increasingly defined by the gravitational pull of a single entity: Eli Lilly and Company (NYSE: LLY)....

Via Finterra

Topics Economy Intellectual Property

Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket ↗

March 31, 2026

The takeover fills a glaring hole in Eli Lilly's pipeline, says one analyst.

Via Investor's Business Daily

2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More ↗

March 31, 2026

There are some tempting bargains if you know where to look.

Via The Motley Fool

Merck Just Made a Big Bet on a New Cancer Growth Engine ↗

March 31, 2026

Via MarketBeat

Stock Market Today, March 30: High Oil Prices Drive Risk-Off Sentiment, Nasdaq Falls 0.7% ↗

March 30, 2026

Inflation and growth worries impacted tech stocks as investors question AI price tags today, March 30, 2026.

Via The Motley Fool

Topics Artificial Intelligence Bonds Economy

Eli Lilly's CEO Says This Could Be a Game Changer for Its Business ↗

March 30, 2026

The healthcare stock may not be running out of growth catalysts anytime soon.

Via The Motley Fool

Nervous About the Market? 3 Vanguard ETFs That Were Made for Times Like These. ↗

March 30, 2026

You can sleep peacefully at night owning these Vanguard ETFs.

Via The Motley Fool

Topics Bonds ETFs Economy

Prediction: Buying Pfizer Stock Today Could Set You Up for Life ↗

March 29, 2026

Pfizer is behind Eli Lilly and Novo Nordisk in the GLP-1 race, but long-term investors shouldn't count the company out.

Via The Motley Fool

Topics Intellectual Property

Eli Lilly Secures $2.75 Billion Deal With Insilico Medicine To Bring AI-Developed Drugs To Global Market: Report ↗

March 29, 2026

Eli Lilly's deal involves an upfront payment of $115 million to Insilico, with additional payments tied to milestones.

Via Benzinga

1 Reason This Biotech Stock Could Triple Before Year-End ↗

March 29, 2026

This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

Via The Motley Fool

1 Reason Eli Lilly Stock Is Still a Buy ↗

March 28, 2026

Eli Lilly is much more than just a weight loss stock.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly

March 27, 2026

INDIANAPOLIS – In a move that has left some retail investors scratching their heads, shares of Eli Lilly and Company (NYSE:LLY) have trended lower this week, despite the pharmaceutical giant releasing...

Via MarketMinute

Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy? ↗

March 27, 2026

It's not much of a contest right now.

Via The Motley Fool

Corporate Fortress: S&P 500 Defies Gravity with Fifth Consecutive Quarter of Double-Digit Growth

March 27, 2026

The American corporate engine has proven far more durable than even the most optimistic analysts predicted just a year ago. As of March 27, 2026, final results for the fourth quarter of 2025 have...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Institutional Investors Are Selling One of Wall Street's Premier Trillion-Dollar Club Members (No, Not Nvidia!) ↗

March 27, 2026

This critical cog of the artificial intelligence (AI) supply chain was notably reduced by Wall Street's savviest money managers and passive funds during the fourth quarter.

Via The Motley Fool

Topics Artificial Intelligence Economy

1 Vanguard Index Fund to Buy Before It Soars 129%, According to a Wall Street Strategist ↗

March 27, 2026

Tom Lee, a veteran Wall Street strategist, says the S&P 500 could hit 15,000 by 2030.

Via The Motley Fool

Topics ETFs Retirement Stocks

Could Buying Eli Lilly Today Set You Up for Life? ↗

March 26, 2026

Eli Lilly is leading the GLP-1 market, and investors are enthralled with the stock.

Via The Motley Fool

Topics Intellectual Property

Wave Life Sciences Shakes Biotech Sector with Breakthrough Obesity Data: A New Era for ‘Quality’ Weight Loss

March 26, 2026

The biotechnology landscape witnessed a defining moment on March 26, 2026, as Wave Life Sciences (Nasdaq: WVE) released highly anticipated interim Phase 1 data from its INLIGHT trial. The study, which...

Via MarketMinute

Firing on All Cylinders: Eli Lilly (NYSE:LLY) Q4 Earnings Lead the Way

March 25, 2026

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Eli Lilly (NYSE:L...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

March 25, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Collegium Pharmaceutical (NASDAQ:COLL) an...

Via StockStory

Topics Artificial Intelligence Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Eli Lilly (NY:LLY)

All News about Eli Lilly

Starting at $3.75/week.

Subscribe Today